下肢钙化评分作为外周动脉疾病负担与截肢风险衡量指标的评估
本研究纳入在埃默里大学血管外科门诊评估并接受主动脉及下肢非增强CT的外周动脉疾病患者50例,采用Agatston法测量主髂、股腘及胫动脉钙化评分。胫动脉钙化评分联合其他已知危险因素可能改善截肢预测,胫动脉钙化评分添加到高脂血症、慢性肾病和趾臂指数后,预测截肢的曲线下面积从0.82提高至0.94(P=0.022)。
要点
- 胫动脉钙化评分最高四分位组截肢频率更高(P<0.005),死亡频率也更高(P=0.041)。
- 单因素分析中慢性肾病、糖尿病、胫动脉钙化评分及双侧总钙化评分与截肢风险增加相关。
- 胫动脉钙化评分加入高脂血症、慢性肾病和趾臂指数后,截肢预测的曲线下面积从0.82提高至0.94(P=0.022)。
核心结论
- 胫动脉钙化评分加入其他已知外周动脉疾病危险因素后,可能改善外周动脉疾病患者截肢的预测。
研究设计与样本
- 在埃默里大学血管外科门诊评估外周动脉疾病并接受主动脉及下肢非增强计算机断层扫描的患者被纳入研究,共50例。
- 采用Agatston法测量主髂、股腘及胫动脉钙化评分,并记录计算机断层扫描6个月内获得的踝臂压力指数和趾臂压力指数,按外周动脉疾病严重程度分类。
- 进行单因素和多因素有序回归分析预测截肢结局,并进行受试者工作特征分析比较下肢钙化评分与其他变量预测截肢的能力。
主要发现
- 50例患者按下肢钙化评分四分位分组,每组12-13例;最高四分位组与其他四分位组相比年龄更大(P=0.016)、糖尿病比例更高(P=0.034)、大截肢频率更高(P=0.004)。
- 胫动脉钙化评分最高四分位组更可能患有3期及以上慢性肾病(P=0.011),截肢频率更高(P<0.005),死亡频率更高(P=0.041)。
- 各解剖部位下肢钙化评分与踝臂压力指数/趾臂压力指数分类之间无显著关联。
- 单因素分析中,慢性肾病(比值比12.92,95%置信区间2.01至82.83,P=0.007)、糖尿病(比值比5.47,95%置信区间1.27至23.64,P=0.023)、胫动脉钙化评分(比值比6.62,95%置信区间1.79至24.54,P=0.005)及双侧总钙化评分(比值比6.32,95%置信区间1.18至33.78,P=0.031)与截肢风险增加相关。
- 多因素逐步有序回归中,趾臂压力指数和胫动脉钙化评分被确定为截肢的重要预测因素,高脂血症和慢性肾病提高模型的整体预测能力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The ankle-brachial pressure index (ABI) and toe-brachial pressure index (TBI) are commonly used diagnostic tools for peripheral artery disease (PAD) that are unreliable in the presence of calcified vessels. In this study, we aimed to demonstrate the utility of the lower extremity calcium score (LECS) in addition to ABI and TBI in measuring disease burden and predicting the risk of amputation in patients with PAD. METHODS: Patients who were evaluated in the vascular surgery clinic at Emory University for PAD and who underwent noncontrast computed tomography of the aorta and lower extremities were included in the study. Aortoiliac, femoral-popliteal, and tibial calcium scores were measured using the Agatston method. ABI and TBI that were obtained within 6 months of the computed tomography scan were noted and divided into categories of PAD severity. Associations between ABI, TBI, and LECS of each anatomic segment were evaluated. Univariate and multivariate ordinal regression analyses were performed to predict the outcome of amputation. Receiver operating characteristic analysis was performed to compare LECS with other variables in its ability to predict amputation. RESULTS: Fifty patients included in the study cohort were divided into LECS quartiles, with 12-13 patients in each quartile. The highest quartile tended to be older (P = 0.016), had a higher percentage of diabetics (P = 0.034), and had a higher frequency of major amputations (P = 0.004) compared to the other quartiles. Patients in the highest quartile of tibial calcium score were more likely to have stage 3 chronic kidney disease (CKD) or greater (P = 0.011) and also had a higher frequency of amputation (P < 0.005) and mortality (P = 0.041). We found no significant association between each anatomic LECS and ABI/TBI categories. On univariate analysis, CKD (Odds Ratio [OR] 12.92 (95% CI 2.01 to 82.83), P = 0.007), diabetes mellitus (OR 5.47 (95% CI 1.27 to 23.64), P = 0.023), tibial calcium score (OR 6.62 (95% CI 1.79 to 24.54), P = 0.005), and total bilateral calcium score (OR 6.32 (95% CI 1.18 to 33.78), P = 0.031) were associated with increased risk of amputation. On multivariate stepwise ordinal regression, TBI and tibial calcium score were identified as important predictors of amputation, with hyperlipidemia and CKD increasing the overall prediction of the model. On Receiver operating characteristic analysis, the addition of the tibial calcium score (area under the curve 0.94, standard error 0.048) significantly improved the prediction of amputation compared to hyperlipidemia, CKD, and TBI alone (area under the curve 0.82, standard error 0.071, P = 0.022). CONCLUSIONS: The addition of tibial calcium score to other known PAD risk factors may improve the prediction of amputation in patients with PAD.
引用
- Lee S, Kalra K, Kashikar A, et al. Evaluation of Lower Extremity Calcium Score as a Measure of Peripheral Arterial Disease Burden and Amputation Risk. Ann Vasc Surg. 2023. PMID: 36889632. doi:10.1016/j.avsg.2023.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。